| Literature DB >> 19906014 |
Ol'ga Vančová1, Ladislav Bačiak, Svatava Kašparová, Jarmila Kucharská, Hector H Palacios, Jaromír Horecký, Gjumrakch Aliev.
Abstract
Brain energy disorders can be present in aged men and animals. To this respect, the mitochondrial and free radical theory of aging postulates that age-associated brain energy disorders are caused by an imbalance between pro- and anti-oxidants that can result in oxidative stress. Our study was designed to investigate brain energy metabolism and the activity of endogenous antioxidants during their lifespan in male Wistar rats. In vivo brain bioenergetics were measured using ³¹P nuclear magnetic resonance (NMR) spectroscopy and in vitro by polarographic analysis of mitochondrial oxidative phosphorylation. When compared to the young controls, a significant decrease of age-dependent mitochondrial respiration and adenosine-3-phosphate (ATP) production measured in vitro correlated with significant reduction of forward creatine kinase reaction (kfor) and with an increase in phosphocreatine (PCr)/ATP, PCr/Pi and PME/ATP ratio measured in vivo. The levels of enzymatic antioxidants catalase, GPx and GST significantly decreased in the brain tissue as well as in the peripheral blood of aged rats. We suppose that mitochondrial dysfunction and oxidative inactivation of endogenous enzymes may participate in age-related disorders of brain energy metabolism.Entities:
Mesh:
Substances:
Year: 2010 PMID: 19906014 PMCID: PMC4373491 DOI: 10.1111/j.1582-4934.2009.00879.x
Source DB: PubMed Journal: J Cell Mol Med ISSN: 1582-1838 Impact factor: 5.310
Brain bioenergetic measurements in young (3 months old) and aged (36 months old) rats by using 31P NMR spectroscopy
| 3 months | 1.94 ± 0.06 | 4.14 ± 0.42 | 0.77 ± 0.09 | 0.35 ± 0.02 | 7.18 ± 0.01 |
| 36 months | 2.12 ± 0.04*** | 5.64 ± 1.44** | 0.84 ± 0.07* | 0.30 ± 0.01*** | 7.16 ± 0.01* |
Data are presented as mean ± S.E.M., ***P < 0.001, **P < 0.01, *P < 0.05 versus 3 months.
Note: Adult (17 months old) rats were not measured due to disruptions in SISCO spectrometer.
Fig 1Changes of brain bioenergetics measured in vivo by 31P MRS in aged (36 months old) compared to young (3 months old) male Wistar rats. MRS, magnetic resonance spectroscopy; PCr/ATP, phosphocreatine to adenosine three phosphate ratio; PCr/Pi, PCr to inorganic phosphate ratio; PME/ATP, phosphate monoester to ATP ratio; kfor, forward rate constant of CK and pHi, intracellular pH. ***P < 0.001, **P < 0.01, *P < 0.05.
Brain and blood antioxidant measurements in adult (10 months old) and aged (36 months old) rats
| SOD (U.g-1) | 170.73 ± 21.43 | 160.63 ± 8.15 |
| CAT (U.ml-1) | 3.63 ± 0.42 | 4.59 ± 0.16 |
| GPX (U.g-1) | 0.84 ± 0.14 | 1.34 ± 0.16* |
| GST (U.g-1) | 2.69 ± 0.17 | 3.09 ± 0.06* |
| FRAP (mmol.g-1) | 4.64 ± 0.27 | 4.87 ± 0.06 |
| CPL (U.g-1) | 0.52 ± 0.04 | 0.07 ± 0.02*** |
| SOD e(U.ml-1) | 197.03 ± 11.06 | 179.83 ± 8.06 |
| CAT e(U.ml-1) | 1232.68 ± 143.68 | 3928.88 ± 155.88*** |
| GPXe(U.ml-1) | 8.83 ± 0.33 | 3.14 ± 0.03*** |
| GST e(U.ml-1) | 3.84 ± 0.36 | 5.70 ± 0.37** |
| FRAP p(mmol.ml-1) | 363.34 ± 32.18… | 315.50 ± 18.90 |
| CPL p (U.ml-1) | 0.14 ± 0.02 | 0.11 ± 0.01 |
Data are presented as mean ± S.E.M. ***P < 0.001, **P < 0.01, *P < 0.05.
Fig 3Percentual changes of endogenous antioxidants activity in brain tissue (A) and in peripheral blood (B) of aged (36 months old) compared to adult (10 months old) male Wistar rats. (A) (brain) ***P < 0.001, *P < 0.05, (B) (blood) ***P < 0.001, **P < 0.01.
Age-dependent mitochondrial OXPHOS activities in young (3 months), adult (17 months) and aged (36 months) male Wistar rats
| Complex I | |||
| RCI (S3.S4–1) | 3.63 ± 0.19 | 3.25 ± 0.12 | 2.86 ± 0.08 |
| ADP:O (nmol ADP.nAtO-1) | 2.67 ± 0.02 | 2.76 ± 0.02 | 2.63 ± 0.04+ |
| QO2S3 (nAtO.mg prot-1.min-1) | 76.73 ± 2.80 | 58.74 ± 2.89 | 48.68 ± 1.76 |
| QO2S4 (nAtO.mg prot-1.min-1) | 21.98 ± 1.52 | 18.16 ± 0.75 | 17.14 ± 0.80 |
| OPR (nmol ATP.mg prot-1.min-1) | 205.23 ± 6.08 | 163.97 ± 9.35 | 127.27 ± 5.26 |
| Complex II | |||
| RCI (S3.S4–1) | 1.66 ± 0.33 | 1.65 ± 0.06 | 1.64 ± 0.04 |
| ADP:O (nmol ADP.nAtO-1) | 1.69 ± 0.03 | 1.63 ± 0.04 | 1.72 ± 0.03 |
| QO2S3 (nAtO.mg prot-1.min-1) | 87.87 ± 4.36 | 68.20 ± 3.97 | 51.04 ± 2.72 |
| QO2S4 (nAtO.mg prot-1.min-1) | 53.02 ± 2.93 | 41.66 ± 2.75 | 31.33 ± 1.99 |
| OPR (nmol ATP.mg prot-1.min-1) | 205.23 ± 6.08 | 163.97 ± 9.35 | 127.27 ± 5.26 |
Data are presented as mean ± S.E.M.
**P < 0.001, **P < 0.01, *P < 0.05 versus 3 month, ++P < 0.01, +P < 0.05 versus 17 month.